Metabolic dysfunction-associated steatotic liver disease and gut microbiota

被引:0
|
作者
Petryna, Vitalii [1 ]
机构
[1] Ivano Frankivsk Natl Med Univ, Ivano Frankivsk, Ukraine
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
WED-555
引用
收藏
页码:S285 / S285
页数:1
相关论文
共 50 条
  • [41] Sexual dimorphism of metabolic dysfunction-associated steatotic liver disease
    Cherubini, Alessandro
    Della Torre, Sara
    Pelusi, Serena
    Valenti, Luca
    TRENDS IN MOLECULAR MEDICINE, 2024, 30 (12) : 1126 - 1136
  • [42] Hepatocellular Carcinoma in Metabolic Dysfunction-Associated Steatotic Liver Disease
    Rodriguez, Luis A.
    Schmittdiel, Julie A.
    Liu, Liyan
    Macdonald, Brock A.
    Balasubramanian, Sreepriya
    Chai, Krisna P.
    Seo, Suk I.
    Mukhtar, Nizar
    Levin, Theodore R.
    Saxena, Varun
    JAMA NETWORK OPEN, 2024, 7 (07) : e2421019
  • [43] Gut microbiota and metabolic biomarkers in metabolic dysfunction-associated steatotic liver disease (MASLD) (vol 8, e0310, 2024)
    Long, Q.
    Luo, F.
    Li, B.
    Li, Z.
    Chen, Z.
    HEPATOLOGY COMMUNICATIONS, 2024, 8 (07)
  • [44] Implications of Microbiota and Immune System in Development and Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease
    Popov, Jelena
    Despot, Tijana
    Rodriguez, David Avelar
    Khan, Irfan
    Mech, Eugene
    Khan, Mahrukh
    Bojadzija, Milan
    Pai, Nikhil
    NUTRIENTS, 2024, 16 (11)
  • [45] Metabolic dysfunction-associated steatotic liver disease and risk of cardiovascular disease
    Lee, Hyeok-Hee
    Lee, Han Ah
    Kim, Eun-Jin
    Kim, Hwi Young
    Kim, Hyeon Chang
    Ahn, Sang Hoon
    Lee, Hokyou
    Kim, Seung Up
    GUT, 2024, 73 (03) : 533 - 540
  • [46] Monitoring disease progression in metabolic dysfunction-associated steatotic liver disease
    Noureddin, Nabil
    Copur-Dahi, Nedret
    Loomba, Rohit
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 59 : S41 - S51
  • [47] Effect of Oral Microbiota Composition on Metabolic Dysfunction-Associated Steatotic Liver Disease in the General Population
    Sato, Satoshi
    Iino, Chikara
    Furusawa, Keisuke
    Yoshida, Kenta
    Chinda, Daisuke
    Sawada, Kaori
    Mikami, Tatsuya
    Nakaji, Shigeyuki
    Fukuda, Shinsaku
    Sakuraba, Hirotake
    JOURNAL OF CLINICAL MEDICINE, 2025, 14 (06)
  • [48] Gut dysbiosis-induced humoral dysregulation in metabolic dysfunction-associated steatotic liver disease
    Cheng, Hong Sheng
    Koo, Yolanda Wei Ling
    Vijay, Esha Bharathwaj
    Chua, Damien
    Wong, Sunny Hei
    Tan, Nguan Soon
    JOURNAL OF HEPATOLOGY, 2024, 80 : S280 - S280
  • [49] Implications of the new nomenclature of steatotic liver disease and definition of metabolic dysfunction-associated steatotic liver disease
    Loomba, Rohit
    Wong, Vincent Wai-Sun
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 59 (02) : 150 - 156
  • [50] METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE IS ASSOCIATED WITH LIVER FIBROSIS IN HEPATITIS C
    Elgretli, Wesal
    Shengir, Mohamed
    Sasson, Solomon
    Agnihotram, V. Ramanakumar
    Ballesteros, Luz Esther Ramos
    Deschenes, Marc
    Wong, Philip
    Chen, Tianyan
    Kronfli, Nadine
    Keeshan, Alexa
    Tandon, Saniya
    Cooper, Curtis
    Sebastiani, Giada
    HEPATOLOGY, 2024, 80 : S382 - S383